Oliver Schramel

Title: Oliver Schramel: Innovator of Cationic Liposomal Preparations

Introduction

Oliver Schramel, an inventive mind from Ismaning, Germany, has made significant strides in the field of pharmaceutical preparations. With a portfolio that includes four patents, his work focuses on the production of cationic liposomal preparations, showcasing his expertise in enhancing the stability and efficacy of lipophilic compounds.

Latest Patents

Oliver is the inventor of two notable patents that share an innovative method of producing a cationic liposomal preparation comprising a lipophilic compound. These patents describe a manufacturing process that ensures physical and chemical stability during the production, storage, and reconstitution of the liposomal preparations. Furthermore, the patents detail the specific cationic liposomal preparations and the pharmaceutical compositions enhanced by these methods.

Career Highlights

Oliver has worked with esteemed companies such as Medigene AG and Medigene Oncology GmbH. His tenure at these organizations has contributed to advancements in oncology and innovative drug delivery systems. His experience in the pharmaceutical industry has played a crucial role in his research and development efforts.

Collaborations

Throughout his career, Oliver has collaborated with talented professionals, including colleagues Carsten Mundus and Christian Welz. These collaborations have fostered an environment of innovation, enhancing the development of his groundbreaking technologies.

Conclusion

With a focus on the production of cationic liposomal preparations, Oliver Schramel embodies the spirit of innovation in the pharmaceutical industry. His contributions are paving the way for more effective drug delivery methods, solidifying his reputation as a noteworthy inventor in the field.